[Form 4] Oxbridge Re Holdings Limited Warrant expiring 3/26/2029 Insider Trading Activity

Rhea-AI Filing Summary

Allan S. Martin, a director of Oxbridge Re Holdings Ltd (OXBR), reported sales of ordinary shares on 08/27/2025. The Form 4 shows two sell transactions: 3,449 shares sold at $2.3948 and 6,551 shares sold at $2.3812. After those transactions the filing reports beneficial ownership figures of 227,682 and 221,131 (reported on separate lines) for the direct holdings shown. The filing also discloses 68,770 ordinary shares held indirectly by Fleur de Lis Partners, LLLP and 102,223 ordinary shares held indirectly by the Martin Family Foundation, Inc., with Mr. Martin described as having voting and/or investment power over those entities' holdings. The form is signed by an attorney-in-fact on 08/29/2025.

Positive

• Insider disclosure completed showing exact sale amounts and prices to satisfy Section 16 reporting

Negative

• Director executed open-market sales of 3,449 and 6,551 ordinary shares on 08/27/2025

Insights

Financial Analyst

TL;DR: Director reported small share sales and holds additional indirect positions via related entities.

The Form 4 documents two open-market sell transactions on 08/27/2025 at prices of $2.3948 and $2.3812 for 3,449 and 6,551 ordinary shares respectively. The filing lists direct beneficial ownership figures of 227,682 and 221,131 following the reported transactions and discloses indirect holdings of 68,770 and 102,223 shares through Fleur de Lis Partners, LLLP and the Martin Family Foundation, Inc. These entries clarify voting and investment power but the form does not provide aggregate percentage ownership of the company or contextual trading rationale.

Corporate Governance Expert

TL;DR: Disclosure shows director's individual sales and governance links to entities holding additional shares.

The report identifies Allan S. Martin as a director and states he has voting and investment authority over shares held by a private partnership and a foundation. The filing includes disclaimers that he disclaims beneficial ownership beyond pecuniary interest for those entities. The Form 4 is signed by an attorney-in-fact, indicating representation in the filing process. The document provides clear provenance of holdings but does not include other governance changes or agreements.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

MARTIN ALLAN S.

(Last) (First) (Middle)

101 E KENNEDY BLVD

SUITE 4110

(Street)

TAMPA FL 33602

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
OXBRIDGE RE HOLDINGS Ltd [ OXBR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/27/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	08/27/2025		S		3,449	D	$2.3948	227,682(1)	D
Ordinary Shares	08/27/2025		S		6,551	D	$2.3812	221,131(1)	D
Ordinary Shares								68,770(2)	I	See footnote 2
Ordinary Shares								102,223(3)	I	See footnote 3

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Ordinary shares held by Allan Martin and his wife, Marie Martin, jointly.

2. Ordinary Shares indirectly held in the name of Fleur de Lis Partners, LLLP. As the general partner of Fleur de Lis Partners, LLLP, Mr. Martin has voting and investment power over the ordinary shares held by that entity. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of the reporting person's pecuniary interest in such securities.

3. Ordinary Shares indirectly held in the name of the Martin Family Foundation, Inc. As one of the directors of the Foundation, Inc. Mr. Martin has shared voting and shared investment power over the ordinary shares held by that entity. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of the reporting person's pecuniary interest in such securities.

	/s/Jacqueline Baker, as Attorney-in-Fact for Allan Martin	08/29/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Allan S. Martin report on the Form 4 for OXBRW?

The Form 4 reports two sales on 08/27/2025: 3,449 shares at $2.3948 and 6,551 shares at $2.3812.

How many shares does the filing show Mr. Martin indirectly controls?

The filing shows Mr. Martin has power over 68,770 shares held by Fleur de Lis Partners, LLLP and 102,223 shares held by the Martin Family Foundation, Inc.

What direct beneficial ownership figures are reported after the transactions?

The Form 4 lists direct beneficial ownership amounts of 227,682 and 221,131 following the reported transactions (reported on separate lines).

When was the Form 4 signed and by whom?

The signature block shows the form was signed by Jacqueline Baker, as Attorney-in-Fact for Allan Martin on 08/29/2025.

What relationship to the issuer is disclosed for the reporting person?

The filing identifies Allan S. Martin as a director of Oxbridge Re Holdings Ltd.